Q1 2021 Lantern Pharma Inc. Earnings Call Transcript
Good afternoon, and welcome to Lantern Pharma's First Quarter 2021 Conference Call. As a reminder, this call is being recorded.
(Operator Instructions)
I would now like to introduce your host for today's conference, Marek Ciszewski with Investor Relations at Lantern Pharma. Marek, please go ahead, sir.
Thank you, Jim. And welcome, everyone, to the Lantern Pharma's First Quarter 2021 Conference Call. On the call today are Panna Sharma, Lanterns' President and CEO; David Margrave, Lanterns' CFO; and Dr. Kerry Barnhart, Lantern's Vice President of Clinical Development.
Our press release was issued today with our first quarter financial results that we will be discussing on our call today. Following the safe harbor statement, Panna will provide an overview of business highlights, after which David will overview our quarterly financial results, and Dr. Barnhart will provide an update on our LP-300 program. Panna will then offer concluding comments, after which we will open this call to questions.
Please also note that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |